Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2020: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
The purpose of this study was to investigate patients who had undergone transcatheter aortic valve implantation (TAVI) and whose cardiac function did not improve sufficiently, and to investigate the appropriate indications for TAVI based on the findings of the study. In patients with improved right ventricular contractility, cardiac output tended to increase after TAVI. It was also found that patients with reduced tricuspid valve annular contractility tended to have less improvement in tricuspid regurgitation after TAVI.
|